Pavel Durov Sperm Program Draws Global Attention as Donor Claims More Than 100 Children

Pavel Durov is back in the news after reports showed that his sperm was offered for years at a Moscow fertility clinic. The Telegram founder said he fathered more than 100 children across many countries. The clinic promoted his sperm as rare and in high demand. The disclosure came after Durov confirmed his donations in 2024.

The issue matters because Durov is one of the most influential tech leaders today. His public comments and large global following make his reproductive choices a major topic. According to Reuters and other major outlets, his sperm remained available long after he stopped donating. The clinic kept using his frozen samples.

Pavel Durov Sperm Program Promoted by Moscow Clinic

The AltraVita clinic in Moscow marketed Pavel Durov’s sperm for years. It placed his photo on its website and promoted his “high genetic compatibility.” It also offered IVF costs paid for women under 37 who used his donor material.

The clinic attracted many women who wanted a child from what they saw as a strong and successful donor. According to AP reporting, a former doctor said most candidates were young, healthy, and well-educated. They were asked to be unmarried to avoid legal issues.

Durov said he first donated sperm around 2010. He began with a friend and later donated anonymously. He said the world has a shortage of healthy sperm and he wanted to help. His post in 2024 revealed he had biological children in at least 12 countries.

His net worth has been estimated at around $17 billion. Durov said his biological children may someday share his estate if they can prove DNA ties. That sparked a wave of messages from people claiming to be his offspring. He later said he plans to release his DNA so his children can find each other.

Global Reaction and Ethical Debate Around Donor Identity

The Pavel Durov sperm story expanded far beyond Russia. Experts say it touches on ethics, identity, and the tech elite’s growing interest in reproduction. Major outlets note that some wealthy figures promote large families or genetic programs. Durov has spoken about declining fertility and said modern life harms reproductive health.

Reuters reported that Russia faces a long-term demographic decline. This has made donor programs more visible. People saw Durov as a rare “elite” donor, which boosted the clinic’s marketing. The clinic has also worked on cloning projects and genetic screening.

Durov has faced pressure from other fronts too. In 2024, he was arrested in France over misuse of Telegram by criminals. He denied wrongdoing. French prosecutors said Telegram has since improved cooperation.

The donor program also drew attention to Durov’s personal life. He has six children with different mothers and continues to be a public figure. His lifestyle, business growth, and legal challenges keep him in headlines.

The Pavel Durov sperm story continues to raise questions about genetics, wealth, and modern parenting. It also shows how one tech figure can shape global debate without trying to. The topic may grow as more details emerge.

FYI (keeping you in the loop)-

Q1: Why is Pavel Durov’s sperm in the news?

It is in the news because a Moscow clinic promoted his donor sperm for years. Reports say he fathered more than 100 children. His comments in 2024 brought new attention.

Q2: Is Pavel Durov still donating sperm?

No. He said he stopped years ago. But the clinic kept his frozen samples and continued offering them.

Q3: How many children does Durov claim?

He said he has more than 100 biological children through donation. He also has six children from personal relationships.

Q4: Why did the clinic promote his identity?

The clinic said he had strong traits and high compatibility. It drew interest from women seeking a donor with his background.

Q5: What are the ethical concerns?

Experts point to issues of consent, identity, and growing use of elite donors. The large number of potential siblings also raises concerns.

Trusted Sources

Reuters, AP News, The Wall Street Journal, BBC News